Publication | Closed Access

Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril

Molecular PharmacologyHypertensionRenal FunctionMedicineAntihypertensive TherapyPhysiologyCardiovascular PharmacologyPharmacotherapyPharmacologyNephrologyAngiotensin-converting Enzyme InhibitionAldosterone ReductionAzotemic PatientsEndocrine Hypertension